Iron as a co-morbid factor in nonhemochromatotic liver disease (Q35212534)

7 August 2017

1 reference

title

Iron as a co-morbid factor in nonhemochromatotic liver disease (English)

1 reference

7 August 2017

Herbert L Bonkovsky

1

1 reference

PubMed ID

12957298

7 August 2017

Richard W Lambrecht

series ordinal

2

1 reference

PubMed ID

12957298

7 August 2017

Ying Shan

series ordinal

3

1 reference

7 August 2017

1 June 2003

1 reference

7 August 2017

1 reference

7 August 2017

30

1 reference

7 August 2017

137-144

1 reference

7 August 2017

2

1 reference

Management of nonalcoholic steatohepatitis: an analytic review

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Nonalcoholic steatohepatitis: an expanded clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Changes in serum iron levels due to infection with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron as a comorbid factor in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron in liver diseases other than hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron and chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron Metabolism in Patients with Porta-Caval Shunts

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

The immunological system in hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Measurements of iron status in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Heterozygosity of the haemochromatosis mutation, C282Y, does not influence susceptibility to alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Postshunt hemochromatosis with cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Hemosiderosis in cirrhosis: a study of 447 native livers

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Review: nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Serum ferritin as a predictor of host response to hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Update on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Spur cell anemia explains the iron overload in advanced cirrhosis (C282Y negative)

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Hemochromatosis gene modifies course of hepatitis C viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Risk factors of fibrosis in alcohol-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Uroporphyria caused by ethanol in Hfe(-/-) mice as a model for porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Experimental liver cirrhosis induced by alcohol and iron

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900127-7

7 January 2021

10.1016/S0741-8329(03)00127-7

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12957298